{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:25:30Z","timestamp":1787606730045,"version":"build-2736575974"},"reference-count":60,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fundacao Oswaldo Cruz"},{"name":"Fundacao de Amparo a pesquisa do Amazonas"},{"name":"Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior"},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"abstract":"<jats:p>ABSTRACT Leptospirosis is a zoonosis with global distribution caused by spirochetes of the genus Leptospira. In regions with poor sanitation, leptospirosis is considered a neglected disease, resulting in approximately one million cases and thousands of deaths annually. Transmission occurs mainly through contact with the urine of infected rodents, and clinical manifestations range from mild symptoms to the severe form known as Weil\u2019s disease. Although licensed vaccines are available, they are targeted at specific risk groups. Bacterins are composed of specific serovars, induce a short-term immune response, and may cause adverse reactions. Advances in molecular biology-including sequencing of the Leptospira genome-have spurred the development of new vaccination strategies, particularly protein subunit vaccines. These vaccines are based on proteins located in the outer membrane of pathogenic Leptospira species. These antigens are expressed in prokaryotic hosts, exhibit high immunogenicity, and, because they are directly exposed to the host\u2019s immune system, are considered promising targets for the development of safer and more effective vaccines. Among the main antigens studied, the most notable are LipL32, LipL41, OmpL1, OmpL37, Loa22, LigA, and LigB. However, the identification of antigens capable of inducing an effective immune response while containing conserved regions across different serovars remains a major challenge in developing a universal vaccine against leptospirosis. This review presents the principal outer membrane proteins of pathogenic Leptospira that are considered promising candidates for new vaccine formulations, as well as their role in inducing the immune response in the human host.<\/jats:p>","DOI":"10.1590\/s1678-9946202668055","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:05:51Z","timestamp":1787605551000},"source":"Crossref","is-referenced-by-count":0,"title":["Advances in the development of a vaccine for the prevention of human leptospirosis: a review"],"prefix":"10.1590","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3909-028X","authenticated-orcid":false,"given":"Michele Silva de","family":"Jesus","sequence":"first","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz Amaz\u00f4nia,  Brazil; Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz Amaz\u00f4nia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3348-5409","authenticated-orcid":false,"given":"Maria Edilene Martins de","family":"Almeida","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz Amaz\u00f4nia,  Brazil; Universidade do Estado do Amazonas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4210-6367","authenticated-orcid":false,"given":"Lu\u00eds Andr\u00e9 Morais","family":"Mari\u00faba","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz Amaz\u00f4nia,  Brazil; Funda\u00e7\u00e3o Oswaldo Cruz-Fiocruz Amaz\u00f4nia,  Brazil; Universidade Federal do Amazonas,  Brazil; Universidade Federal do Amazonas,  Brazil; Fiocruz Rond\u00f4nia,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.26633\/RPSP.2020.78","article-title":"A systematic literature review of leptospirosis outbreaks worldwide, 1970-2012","volume":"44","author":"Munoz-Zanzi C","year":"2020","journal-title":"Rev Panam Salud Publica"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.vetmic.2009.03.012","article-title":"Leptospira and leptospirosis","volume":"140","author":"Adler B","year":"2010","journal-title":"Vet Microbiol"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.002059","article-title":"Shaping the future of Leptospira serotyping","volume":"74","author":"Giraud-Gatineau A","year":"2025","journal-title":"J Med Microbiol"},{"key":"ref4","series-title":"Leptospirose: diagn\u00f3stico e manejo cl\u00ednico","year":"2014"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/ijms18010158","article-title":"Reverse vaccinology: an approach for identifying leptospiral vaccine candidates","volume":"18","author":"Dellagostin OA","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.4161\/hv.7.11.17944","article-title":"Recombinant vaccines against leptospirosis","volume":"7","author":"Dellagostin OA","year":"2011","journal-title":"Hum Vaccin"},{"key":"ref7","first-page":"459","article-title":"Vacina inativada associada \u00e0 prote\u00edna de membrana externa contra leptospirose","volume":"1","author":"Silveira MM","year":"2018","journal-title":"Braz J Anim Environ Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12866-016-0852-y","article-title":"Chimeric epitope vaccine against Leptospira interrogans infection and induced specific immunity in guinea pigs","volume":"16","author":"Lin X","year":"2016","journal-title":"BMC Microbiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2217\/fmb.10.102","article-title":"Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses","volume":"5","author":"Evangelista KV","year":"2010","journal-title":"Future Microbiol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13316","article-title":"Human leptospirosis: in search for a better vaccine","volume":"98","author":"Azevedo IR","year":"2023","journal-title":"Scand J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1128\/IAI.00131-12","article-title":"FlaA proteins in Leptospira interrogans are essential for motility and virulence but are not required for formation of the flagellum sheath","volume":"80","author":"Lambert A","year":"2012","journal-title":"Infect Immun"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.230101","article-title":"Differential modulation of innate immune response by lipopolysaccharide of Leptospira","volume":"13","author":"Varma VP","year":"2023","journal-title":"Open Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.4049\/jimmunol.0900506","article-title":"TLR4- and TLR2-mediated B cell responses control the clearance of the bacterial pathogen, Leptospira interrogans","volume":"183","author":"Chassim C","year":"2009","journal-title":"J Immunol"},{"key":"ref14","series-title":"Spirochete biology: the post genomic era","first-page":"163","volume-title":"Interaction of Leptospira with the innate immune system","author":"Werts C","year":"2018"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.ki.5000119","article-title":"Toll-like receptor 2 mediates early inflammation by leptospiral outer membrane proteins in proximal tubule cells","volume":"69","author":"Yang CW","year":"2006","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1080\/21505594.2021.1993427","article-title":"The leptospiral LipL21 and LipL41 proteins exhibit a broad spectrum of interactions with host cell components","volume":"12","author":"Takahashi MB","year":"2021","journal-title":"Virulence"},{"key":"ref17","first-page":"65","article-title":"Leptospirosis in humans","volume":"387","author":"Haake DA","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1017\/S0022172400034963","article-title":"Vaccination of guinea-pigs and human beings against leptospiral infections","volume":"37","author":"Smith J","year":"1937","journal-title":"J Hyg. (Lond)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1084\/jem.27.5.593","article-title":"Further study on the cultural conditions of Leptospira (Spirochaeta) icterohaemorrhagiae","volume":"27","author":"Noguchi H","year":"1918","journal-title":"J Exp Med"},{"key":"ref20","first-page":"251","article-title":"Vaccines against leptospirosis","volume":"387","author":"Adler B","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.760291","article-title":"Revisiting the development of vaccines against pathogenic Leptospira: innovative approaches, present challenges, and future perspectives","volume":"12","author":"Barazzone GC","year":"2022","journal-title":"Front Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1080\/21645515.2017.1405884","article-title":"Human leptospirosis vaccines in China","volume":"14","author":"Xu Y","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1469-0691.2007.01662.x","article-title":"Safety and immunogenicity of subcutaneous or intramuscular administration of a monovalent inactivated vaccine against Leptospira interrogans serogroup Icterohaemorrhagiae in healthy volunteers","volume":"13","author":"Laurichesse H","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1590\/S1020-49892004000400005","article-title":"Eficacia y seguridad de una vacuna contra la leptospirosis humana en Cuba","volume":"15","author":"Martinez R","year":"2004","journal-title":"Rev Panam Salud Publica"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1590\/S0100-879X2004000400003","article-title":"Leptospira interrogans genome features","volume":"37","author":"Nascimento AL","year":"2004","journal-title":"Braz J Med Biol Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrmicro2208","article-title":"Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen","volume":"7","author":"Ko AI","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1199660","article-title":"Evaluation of Leptospira interrogans knockdown mutants for LipL32, LipL41, LipL21, and OmpL1 proteins","volume":"14","author":"Fernandes LG","year":"2023","journal-title":"Front Microbiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1128\/IAI.67.12.6572-6582.1999","article-title":"Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection","volume":"67","author":"Haake DA","year":"1999","journal-title":"Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142821","article-title":"Evaluation of the Leptospira interrogans outer membrane protein OmpL37 as a vaccine candidate","volume":"10","author":"Oliveira TL","year":"2015","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2023.100382","article-title":"The leptospiral OmpA-like protein (Loa22) is a surface-exposed antigen that elicits bactericidal antibody against heterologous Leptospira","volume":"15","author":"Schuler EJ","year":"2023","journal-title":"Vaccine X"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-3083.2010.02505.x","article-title":"Leptospirosis: aspects of innate immunity, immunopathogenesis and immune evasion from the complement system","volume":"73","author":"Fraga TR","year":"2011","journal-title":"Scand J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.vetmic.2012.11.005","article-title":"The lipoprotein LipL32: an enigma of leptospiral biology","volume":"162","author":"Murray GL","year":"2013","journal-title":"Vet Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vaccine.2007.10.052","article-title":"Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge","volume":"26","author":"Seixas FK","year":"2007","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/CVI.05720-11","article-title":"Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin","volume":"19","author":"Grassmann AA","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1139\/w06-138","article-title":"Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis","volume":"53","author":"Seixas FK","year":"2007","journal-title":"Can J Microbiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1128\/IAI.71.5.2414-2421.2003","article-title":"LipL21 is a novel surface-exposed lipoprotein of pathogenic Leptospira species","volume":"71","author":"Cullen PA","year":"2003","journal-title":"Infect Immun"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.meegid.2008.10.012","article-title":"Genetic diversity of the leptospiral immnoglobulin-like (Lig) genes in pathogenic Leptospira spp","volume":"9","author":"McBride AJ","year":"2009","journal-title":"Infect Genet Evol"},{"key":"ref38","series-title":"Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species: US8802835B2 United States patent","author":"Ko AI"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180004","article-title":"Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis","volume":"12","author":"Evangelista KV","year":"2017","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"14560","DOI":"10.1073\/pnas.0603979103","article-title":"Genome reduction in Leptospira borgpetersenii reflects limited transmission potential","volume":"103","author":"Bulach DM","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1128\/IAI.01635-06","article-title":"Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen","volume":"75","author":"Choy HA","year":"2007","journal-title":"Infect Immun"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","article-title":"Reverse vaccinology","volume":"3","author":"Rappuoli R","year":"2000","journal-title":"Curr Opin Microbiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.vaccine.2019.02.010","article-title":"Evaluation of different strategies to promote a protective immune response against leptospirosis using a recombinant LigA and LigB chimera","volume":"37","author":"Cunha CE","year":"2019","journal-title":"Vaccine"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijid.2017.01.032","article-title":"Immune response and protective profile elicited by a multi-epitope chimeric protein derived from Leptospira interrogans","volume":"57","author":"Fernandes LG","year":"2017","journal-title":"Int J Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.vaccine.2018.12.050","article-title":"Recombinant BCG strains expressing chimeric proteins derived from Leptospira protect hamsters against leptospirosis","volume":"37","author":"Oliveira TL","year":"2019","journal-title":"Vaccine"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00253-024-13196-1","article-title":"Chimeric lipoproteins for leptospirosis vaccine: immunogenicity and protective potential","volume":"108","author":"Tapaj\u00f3z RC","year":"2024","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/ijmr.IJMR_1022_16","article-title":"Advances & challenges in leptospiral vaccine development","volume":"147","author":"Bashiru G","year":"2018","journal-title":"Indian J Med Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1016\/j.vaccine.2017.08.067","article-title":"DNA vaccines against leptospirosis: a literature review","volume":"35","author":"Silveira MM","year":"2017","journal-title":"Vaccine"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/CVI.00601-12","article-title":"A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis","volume":"20","author":"Forster KM","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4014\/jmb.1408.08007","article-title":"Immunogenicity of a DNA and recombinant protein vaccine combining LipL32 and Loa22 for leptospirosis using chitosanas a delivery system","volume":"25","author":"Umthong S","year":"2015","journal-title":"J Microbiol Biotechnol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1080\/21645515.2015.1047117","article-title":"Immunogenicity of a novel enhance consensus DNA vaccine encoding the leptospiral protein LipL45","volume":"11","author":"Vijayachari P","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nature01597","article-title":"Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing","volume":"422","author":"Ren SX","year":"2003","journal-title":"Nature"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1128\/JB.186.7.2164-2172.2004","article-title":"Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis","volume":"186","author":"Nascimento AL","year":"2004","journal-title":"J Bacteriol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fimmu.2017.00463","article-title":"Discovery of novel leptospirosis vaccine candidates using reverse and structural vaccinology","volume":"8","author":"Grassmann AA","year":"2017","journal-title":"Front Immunol"},{"key":"ref55","article-title":"Challenges for the development of a universal vaccine against leptospirosis revealed by the evaluation of 22 vaccine candidates","volume":"12","author":"Maia MA","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.vaccine.2012.11.028","article-title":"Evaluation of 238 antigens of Leptospira borgpetersenii serovar Hardjo for protection against kidney colonisation","volume":"31","author":"Murray GL","year":"2013","journal-title":"Vaccine"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines: a new era in vaccinology","volume":"17","author":"Pardi N","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.3390\/ijms24032700","article-title":"A comprehensive review of mRNA vaccines","volume":"24","author":"Gote V","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref59","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.128099","article-title":"mRNA vaccines targeting Leptospira immunoglobulin-like proteins confer partial protection in a hamster model of leptospirosis","volume":"73","author":"Techawiwattanaboon T","year":"2026","journal-title":"Vaccine"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-023-01408-5","article-title":"Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases","volume":"8","author":"Wang S","year":"2023","journal-title":"Sig Transduct Target Ther"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0036-46652026000100609&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:06:01Z","timestamp":1787605561000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652026000100609&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":60,"alternative-id":["S0036-46652026000100609"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202668055","relation":{},"ISSN":["1678-9946"],"issn-type":[{"value":"1678-9946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e55"}}